Conclusions  Prior history of incarceration does not appear to impact primary care office-based treatment of opioid dependence with buprenorphine/naloxone.
Community health care providers can be reassured that initiating buprenorphine/naloxone in opioid dependent individuals with
a history of incarceration will have similar outcomes as those without this history.

Content Type Journal ArticleCategory Original ArticleDOI 10.1007/s11606-010-1306-0Authors
Emily A. Wang, Yale University School of Medicine Department of Internal Medicine New Haven CT USABrent A. Moore, Yale University School of Medicine Department of Psychiatry New Haven CT USALynn E. Sullivan, Yale University School of Medicine Department of Internal Medicine New Haven CT USADavid A. Fiellin, Yale Univers…